Principal Financial Group Inc. Buys 75,409 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Principal Financial Group Inc. lifted its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 17.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 505,853 shares of the company’s stock after acquiring an additional 75,409 shares during the quarter. Principal Financial Group Inc. owned 2.80% of Addus HomeCare worth $67,293,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. UMB Bank n.a. grew its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares during the period. Quest Partners LLC bought a new stake in Addus HomeCare during the second quarter valued at approximately $31,000. EntryPoint Capital LLC bought a new stake in Addus HomeCare during the first quarter valued at approximately $44,000. Innealta Capital LLC bought a new stake in Addus HomeCare during the second quarter valued at approximately $44,000. Finally, Farther Finance Advisors LLC grew its position in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock worth $3,050,082 over the last quarter. Insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the subject of several recent research reports. Stephens boosted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp initiated coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, TD Cowen lifted their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Stock Performance

Shares of ADUS opened at $127.58 on Friday. The company’s fifty day moving average is $129.60 and its 200 day moving average is $121.40. Addus HomeCare Co. has a fifty-two week low of $81.51 and a fifty-two week high of $136.12. The stock has a market capitalization of $2.31 billion, a PE ratio of 29.19, a P/E/G ratio of 2.30 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter in the previous year, the business posted $1.03 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. As a group, research analysts forecast that Addus HomeCare Co. will post 4.57 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.